Possibility of a New Anti-Alzheimerʼs Disease Pharmaceutical Composition Combining Memantine and Vitamin D
- 1 February 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 29 (2), 81-91
- https://doi.org/10.2165/11597550-000000000-00000
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Alzheimer's disease - input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trialTrials, 2011
- 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrierFluids and Barriers of the CNS, 2011
- Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s diseaseActa Neuropathologica, 2010
- Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s DiseaseMolecular Neurobiology, 2010
- Coupling of the NMDA receptor to neuroprotective and neurodestructive eventsBiochemical Society Transactions, 2009
- Genome-wide Association Study Implicates a Chromosome 12 Risk Locus for Late-Onset Alzheimer DiseaseAmerican Journal of Human Genetics, 2009
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null MiceEndocrine Reviews, 2008
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the storeAging Cell, 2007
- Glutamate: its role in learning, memory, and the aging brainPsychopharmacology, 1993